The SEC’s judgment against Crews includes over 530,000 USD in disgorged profits and a civil penalty. Judge Tiffany Johnson’s ruling permanently prohibits Crews from engaging in future securities law violations.
Crews, who falsely claimed ties to legitimate medical and biotech firms, misled investors by asserting operational stem cell treatments. His fraudulent activities affected approximately 200 investors.
Leave a Reply